<DOC>
	<DOC>NCT01674686</DOC>
	<brief_summary>The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina.</brief_summary>
	<brief_title>The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris, Variant</mesh_term>
	<mesh_term>Coronary Vasospasm</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<mesh_term>Sarpogrelate</mesh_term>
	<criteria>Clinical history of chest pain compatible with variant angina; morning chest pain aggravated by cold exposure. Angiographically proven coronary spasm; TIMI flow &lt; 3 by spontaneous coronary spasm or intracoronary ergonovine spasm provocation test. Cardiac arrest by coronary spasm Left main coronary spasm Significant fixed coronary artery stenosis; Diameter stenosis &gt; 70% in the major epicardial artery by coronary angiography Left ventricular ejection fraction &lt; 30% Coagulation disorders or bleeding tendency (Platelet count &lt; 50k, PT INR &gt; 2.0) Significant liver disease (AST or ALT &gt; 100 U/ml) Renal failure (SCr &gt; 2.0 mg/dl) hypersensitivity for statin Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Vasospasm</keyword>
	<keyword>Sarpogrelate</keyword>
	<keyword>Statin</keyword>
</DOC>